Vor Biopharma Inc. (VOR)
VOR Stock Price Chart
Explore Vor Biopharma Inc. interactive price chart. Choose custom timeframes to analyze VOR price movements and trends.
VOR Company Profile
Discover essential business fundamentals and corporate details for Vor Biopharma Inc. (VOR) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Biotechnology
IPO Date
5 Feb 2021
Employees
159.00
Website
https://www.vorbio.comCEO
Jean-Paul Kress
Description
Vor Biopharma, Inc. is a clinical-stage biotechnology firm dedicated to developing innovative engineered hematopoietic stem cell (eHSC) therapies for individuals battling cancer. Its lead product candidate, VOR33, is an eHSC therapy currently undergoing Phase 1/2 clinical trials. VOR33 is designed to target acute myeloid leukemia (AML) and various other hematological malignancies. A key feature of VOR33's eHSCs is their engineered absence of the CD33 protein, which is commonly found on AML blood cancer cells. The company's eHSC platform is intended to enable a range of targeted blood cancer treatments, including CAR-T cell therapies, bispecific antibodies, and antibody-drug conjugates. Vor Biopharma has established a partnership with Akron BioProducts for the development and manufacturing of cGMP nucleases. Established in 2015, the company's headquarters are located in Cambridge, Massachusetts.
VOR Financial Timeline
Browse a chronological timeline of Vor Biopharma Inc. corporate events including earnings releases, dividend announcements, and stock splits.
Upcoming earnings on 11 Aug 2026
EPS estimate is -$0.69.
Earnings released on 13 May 2026
EPS came in at -$0.73 surpassing the estimated -$0.75 by +2.67%.
Earnings released on 30 Mar 2026
EPS came in at $44.50 surpassing the estimated -$1.14 by +4.00k%.
Earnings released on 13 Nov 2025
EPS came in at -$3.33 falling short of the estimated -$3.06 by -8.82%.
Stock split effective on 19 Sept 2025
Shares were split 1 : 20 , changing the number of shares outstanding and the price per share accordingly.
Earnings released on 12 Aug 2025
EPS came in at -$43.60 falling short of the estimated -$11.40 by -282.46%.
Earnings released on 14 May 2025
EPS came in at -$0.26 falling short of the estimated -$0.25 by -4.00%.
Earnings released on 20 Mar 2025
EPS came in at -$0.44 falling short of the estimated -$0.34 by -29.41%.
Earnings released on 7 Nov 2024
EPS came in at -$0.40 matching the estimated -$0.40.
Earnings released on 8 Aug 2024
EPS came in at -$0.41 matching the estimated -$0.41.
Earnings released on 9 May 2024
EPS came in at -$0.45 falling short of the estimated -$0.37 by -21.62%.
Earnings released on 20 Mar 2024
EPS came in at -$0.39 surpassing the estimated -$0.49 by +20.41%, while revenue for the quarter reached $12.23m .
Earnings released on 7 Nov 2023
EPS came in at -$0.49 falling short of the estimated -$0.46 by -6.52%.
Earnings released on 10 Aug 2023
EPS came in at -$0.45 falling short of the estimated -$0.42 by -7.14%.
Earnings released on 11 May 2023
EPS came in at -$0.43 falling short of the estimated -$0.38 by -13.16%.
Earnings released on 23 Mar 2023
EPS came in at -$0.53 surpassing the estimated -$0.56 by +5.36%.
Earnings released on 10 Nov 2022
EPS came in at -$0.63 falling short of the estimated -$0.60 by -5.00%.
Earnings released on 11 Aug 2022
EPS came in at -$0.58 surpassing the estimated -$0.67 by +13.43%.
Earnings released on 12 May 2022
EPS came in at -$0.61 falling short of the estimated -$0.54 by -12.96%.
Earnings released on 14 Mar 2022
EPS came in at -$0.49 surpassing the estimated -$0.55 by +10.91%.
Earnings released on 10 Nov 2021
EPS came in at -$0.50 surpassing the estimated -$0.58 by +13.79%.
Earnings released on 9 Aug 2021
EPS came in at -$0.50 falling short of the estimated -$0.47 by -6.38%.
VOR Stock Performance
Access detailed VOR performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.
